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Abstract
Background: People with dementia (PwD) vary in the degree of awareness they show about their situation, both
generally concerning the diagnosis and more specifically around certain aspects or objects of awareness such as
awareness of memory impairment, altered daily activities or social functioning. The extent of awareness or lack of
awareness has consequences for well-being of PwD and carers, impacting on rates of hospital admission,
institutionalization, mood, adjustment to diagnosis, outcomes from intervention and carer burden. An accurate estimation
of a person’s awareness could therefore be useful in a clinical setting to support PwD and their carers in making
appropriate choices for health and care decisions, and could facilitate safe management by health care professionals, e.g.
in an acute care setting. There is a range of different approaches to measuring awareness reported in the dementia
research literature, with varying estimates of the frequency of lack of awareness, reflecting different methodologies and
populations. The majority of the methods have been developed for research purposes and may not be suitable for
clinical use. There are no recent scoping or systematic reviews of the available methods.
Method: We will conduct a scoping review of published studies that have assessed awareness in people with dementia
of all types, and all degrees of severity. The systematic search will include the electronic databases PubMed, Embase,
PsycInfo, CINAHL, Web of Science and Cochrane Library, using search terms for dementia (“dement*” or “Alzheimer*” or
“Pick’s disease”) and “awareness”, “unawareness”, “anosognosia”, “insight”, “denial”, “metacognit*” or “discrepanc*” identified
from pilot searches. Findings will be mapped and described according to the method used, the setting and diagnosis
and the object of awareness studied if specified. Validated measures will be identified.
Discussion: This scoping review will provide an overview of the methods used to measure awareness in people
with dementia, allowing comparison of the methods along with identification of validated measures. The methods or
components will be appraised for potential clinical use, and gaps in research will be highlighted.
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Background
A diagnosis of dementia (or major neurocognitive dis-
order) is made from the history and observation of
acquired cognitive impairment, with a decline in func-
tioning [1], or a decline in mental ability severe enough
to interfere with independence and daily life [2]. People
with dementia (PwD) show varying degrees of recogni-
tion or acknowledgement of impairment or of the result-
ing changes in their abilities. Estimates of the number of
PwD who lack awareness of their difficulties range from
20 to 81%, depending on how it is measured, the degree
of dementia severity and in which cultural or geograph-
ical population it is measured [3, 4].
Awareness is an important concept for discussions
around optimising support for PwD, for several reasons.
Lack of awareness of personal limitations is a predictor
of risk of unsafe behaviour, hospital admission and
institutionalization for PwD [5]. Conversely, some PwD
underestimate their abilities, for example, in the more
complex realm of social and emotional functioning [6],
which might lead to unnecessary avoidance of activities
that could be safely managed and enjoyed. In some situ-
ations, PwD may be more accurate than carers at ap-
praising their abilities in functional tasks [7], which
again could result in conflict or inappropriate
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restrictions. Lack of awareness of performance or func-
tioning is associated with increased stress for the carer
[8, 9] and poorer perceived quality of relationships with
the person with dementia [10] which may indirectly im-
pact negatively on quality of life for PwD [11].
Accurate measurement of awareness could lead to a
better understanding of the individual’s experience, and
a tailored approach to planning of everyday care and ac-
tivities. Awareness is not routinely assessed in the diag-
nosis or structured reviews of dementia, but this could
be beneficial in a healthcare setting, possibly enabling
improved communication and involvement in personal
health care decisions. Appreciating the unique perspec-
tive of the person with dementia would facilitate health
care professionals and family carers in offering person-
centred care. Higher awareness has been associated with
better outcomes of cognitive rehabilitation [12], and rat-
ings could be used to select appropriate interventions.
Ability to measure changes in awareness over time
would also be relevant for care reviews or perhaps in
assessing the impact of interventions. Distinct from a
judgement of capacity which is based on sufficient mem-
ory and understanding to make a specific decision at a
point in time, information about a person’s awareness
might help in an acute care setting. For example, under-
standing a person’s level of awareness may assist in
management decisions around home discharge or self-
administration of medication or could contribute in
later-stage dementia to “best interest” decisions.
The literature includes a range of terms to describe
awareness and similar, related concepts derived from differ-
ing theoretical models. “Anosognosia” was initially used to
define a specific neurological deficit [13], but has now been
broadened to describe a lack of awareness of deficits in dif-
ferent conditions, including dementia, and over a range of
domains [14]. “Insight”, originating from psychiatry, is used
sometimes interchangeably with awareness, or sometimes
as the wider awareness of having a clinical condition and its
implications [15]. “Denial” of symptoms or diagnosis sug-
gests psychological factors and personality traits influencing
acceptance of the condition [16] and can present as a lack
of awareness in dementia. “Metacognition” has been used
to describe self-awareness [17] and implies self-reflection,
which may lead to acknowledgement of the condition and
its impact. Awareness has sometimes been measured as a
global construct but ideally should be construed as mean-
ing awareness of something, which can be described as an
“object” of awareness, e.g. awareness of memory problems,
of functioning in daily activities or of physical symptoms, or
of social and emotional functioning [15]. The object should
be specified in research studies as it influences the degree
of awareness elicited [6]. Awareness of different objects
may operate at different “levels”, i.e. registering and
responding to basic sensory information, monitoring
performance as it takes place, making evaluative judge-
ments or making general appraisals of the situation [18].
Awareness can also be implied through observed responses
and behaviour rather than explicitly shown, although few
studies have measured this [19, 20].
We will use the term “awareness” as a broad and neutral
term encompassing the phenomena, or clinical manifesta-
tions, uniting these concepts. We define this as “the ability
to hold a reasonable or realistic perception or appraisal of,
and/or respond accordingly to, a given aspect of one’s
environment, situation, functioning or performance” [21]
p., 20. This description allows for discussion of retained
awareness or reduced awareness, as well as accommodation
of cognitive models which include explicit and implicit
awareness [20]. It also supports the idea of neurological
and psychosocial influences, with awareness across a range
of different objects [22] and at different levels [18].
A range of methods have been devised to measure
awareness in dementia, mainly in research settings, with
a minority developed specifically for clinical use, for ex-
ample, the Structured Interview for Insight and Judg-
ment in Dementia [5] and the Abridged Anosognosia
Questionnaire [23]. Both quantitative and qualitative re-
search approaches have been used, mainly with people
with early-stage dementia. Some observational tech-
niques are particularly suited to measuring awareness in
people with more severe dementia, in a residential set-
ting [24]. Quantitative measures of awareness are typic-
ally based on either ratings from clinician interviews
[25] or questionnaires measuring a discrepancy between
participant and informant ratings [26], or the discrep-
ancy between self-rating and performance on a cognitive
or functional task [7]. Different judgements may be re-
quired by the participants, e.g. reporting severity of
problems, frequency of problems and changes in abilities
such as no longer managing finances or cooking, over
different durations of time or in comparison to healthy
individuals. The resultant score may be presented on a
scale of awareness [27] or as a dichotomous result, i.e.
aware or unaware [28]. Multi-dimensional measures of
awareness have been used to provide comprehensive in-
formation [8] but are lengthy and would be unsuitable
for use in a clinical setting. Other methods have been
developed to measure awareness in different popula-
tions, e.g. post-traumatic head injury, but may not be ap-
propriate for use in a typically older age group with a
progressive condition such as dementia.
To fully appraise the most appropriate methods for meas-
uring awareness in a clinical setting, it would be helpful to
have an overview of the approaches taken across the range
of settings, and with people at differing stages of dementia.
A preliminary search of the literature finds older reviews of
methods and measures [29], and more recent systematic re-
views that look at different aspects of awareness, e.g.
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concepts of awareness in dementia [30], more narrowly de-
fined reviews [4, 31] and narrative reviews [17, 32]. To date,
we have found no recent comprehensive systematic reviews
or scoping reviews in English, of methods of measuring
awareness in dementia.
We will therefore conduct a scoping review to map the
literature concerning original studies that measure aware-
ness in people with dementia. This will give an overview
of the breadth of methods used and allow exploration of
the characteristics and utility of the methods. A scoping
method has been chosen as, whilst conducted in a rigor-
ous and systematic way, it allows flexibility to include
quantitative and qualitative studies, as well as case studies,
which reflect clinical and research practice for assessing
awareness. We will also identify the validated measures in
use, allowing further appraisal of these methods and com-
ponents, in consideration of potential clinical use. We will
follow the Preferred Reporting Items for Systematic Re-
views and Meta-Analyses (PRISMA) guidelines for con-
ducting the review and preparing the report [33–35].
Methods/design
Objectives
This scoping review seeks to answer the question “What
methods and measures are used to assess awareness in
people with dementia, and what are the characteristics
and utility of each method?” We will systematically scope
the literature, following the framework outlined initially
by Arksey and O’Malley [36], with further guidance from
later publications [35, 37, 38]. This will result in mapping
the literature to allow an overview and description of the
methods, and provide a platform for future studies.
Alongside studies on awareness, the review will include
studies using alternative terminology of “anosognosia”,
“insight”, “denial”, "unawareness", and “metacognition” in
PwD, as these terms are also used in the literature, as pre-
viously discussed, along with studies that measure the dis-
crepancy between self- and informant ratings of relevant
issues, or discrepancy between self-rating and objective
performance, where this has been interpreted as a meas-
ure of awareness. We will include studies addressing any
object of awareness, e.g. awareness of memory or of activ-
ities of daily living and other objects, as well as studies
that do not specify a particular object.
Search strategy
A search of relevant, peer-reviewed, published literature
will be made from the following electronic bibliographic
databases: PubMed, Embase, PsycInfo, Cumulative Index
to Nursing and Allied Health Literature (CINAHL)
complete, Web of Science Core collection, Cochrane Li-
brary. The following search terms were developed for use
from earlier pilot searches with identification of keywords
from relevant articles, and in consultation with experienced
researchers and librarians: (dement* OR Alzheimer* OR
“Pick’s disease”) AND (aware* OR unaware* OR anosogno-
sia OR insight OR denial OR metacognit* OR discrepanc*),
with unlimited date range and no language restriction (see
attached search strategy Additional file 1). We included
“Pick’s disease” as an additional term (whilst excluding Nie-
mann Pick), to find older studies of frontotemporal demen-
tia that may have used this diagnostic label, as pilot
searches showed that it was not otherwise detected using
the search terms dement* and Alzheimer*. Duplicate re-
cords will be removed. Titles/abstracts will be screened for
removal of irrelevant articles. The remaining full texts will
be examined according to pre-arranged eligibility criteria
to produce a list of the final articles to include in the re-
view. Title and abstract screening will be performed inde-
pendently by two researchers, and at full text screening, a
second researcher will screen a 10% sample of the articles
for selection. Any differences will be discussed and, if re-
quired, resolved by consultation with a third senior re-
searcher. To prevent conflicts of interest, review team
members who have authored reports of studies being con-
sidered for inclusion at any stage of the selection process
will not be involved in decisions about the inclusion of
those studies.
Study selection
Population
We will include studies measuring awareness (or equiva-
lent term) in people with a clinical diagnosis of demen-
tia, of any type or severity of dementia. Studies will be
included from community, outpatient, in-patient and
residential settings, with no limitations of age, gender or
ethnicity. Studies reporting on mixed populations will be
included if at least 50% of the study population has the
relevant clinical diagnosis of dementia and if the data for
the dementia subgroup is separately identifiable.
Concepts
Studies that measure awareness in PwD using standard-
ized tools or new methods devised for that study will be
included. We will include studies measuring awareness
as a global construct, or of specific objects, e.g. aware-
ness of memory, functional ability, socio-emotional func-
tioning [22] or if defined at different levels, e.g. sensory
perception, performance monitoring/on-line awareness,
evaluative judgement and metacognitive awareness [18].
Context
Study selection will focus on articles published in English,
where full text is available. Quantitative, mixed method,
qualitative studies and case studies will be included. Mul-
tiple reports that use data from the same study will be
identified and collated, to avoid duplication of findings.
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Exclusion criteria
 Mild cognitive impairment or non-dementia
diagnosis
 Information regarding dementia participants is not
separately identifiable
 Did not measure awareness construct in people
with dementia
 Full text not readily available or not in English
 Review/editorials/letters to editor with no original
findings
 Non-peer reviewed material
 Conference abstracts
 Errata/correction of no significance to required data
Exclusion decisions and characteristics of excluded
studies will be recorded. The search findings will be
summarised using a PRISMA flow diagram [39].
Data extraction and mapping results
Standard information, agreed in team discussions after
earlier pilots of data retrieval, will be recorded for each
included study and charted according to key characteris-
tics. A database will be used to record findings and may
be refined during the review process.
Collating, summarising and reporting results
Overall results will be tabulated according to the method
used and population studied, including diagnosis and se-
verity of dementia, setting, type of study and definitions
used and object of awareness studied. This will show the
breadth of methods used, leading to a basic numerical
summary. In keeping with published scoping review
guidance [36–38], we will not formally assess quality of
included studies. Themes will be explored, with a focus
on describing the characteristics and utility of the
methods, and identifying standardized tools, in keeping
with the research objectives. This will be an iterative
process, leading to a narrative report of the findings.
Consultation with experts in the field will be considered
at this stage, to add validity to the findings and help in-
form future research.
Dissemination and ethics
The completed review will be written up and submitted
for journal publication. In addition, preliminary findings
will be presented as a conference poster. Ethical ap-
proval is not required for this study.
Discussion
This scoping review will provide an overview of the
methods used to measure awareness in people with de-
mentia, allowing comparison of the methods and recog-
nition of gaps in research. It will also identify validated
measures, to allow further appraisal of the properties of
these measures or components, in consideration of po-
tential clinical use. Acknowledging gaps in research, and
strengths and limitations of methods employed, will help
direct further research in this area.
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